Prot#M14-533: A Phase 3 multicenter, open-label extension (OLE) study to evaluate the long-term safety and efficacy of ABT-494 in subjects with ulcerative colitis (UC)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/29/20 → 7/29/23

Funding

  • AbbVie Inc. (Prot#M14-533)